Dose based on m² [General Sta­tis­tics]

posted by Dr_Dan  – Germany, 2013-07-17 13:09 (4717 d 09:57 ago) – Posting: # 10993
Views: 11,407

Dear VK
What do you mean by "We did regular calculations"? In a cross-over study BE is based on the intra-individual comparison of test and reference and therefore it is theoretically possible to administer different doses (dose adjusted PK parameters). However, I guess in your case you administered a combination of different strengths (=different products), right?
For example:
70% received 1x100mg
30% received either 1x50mg+1x25mg or 1x100mg+1x25mg
Then indeed only 70% of the subjects could be evaluated since a pure comparison is only possible between your 100 mg product and the originator.
If you had choosen
70% received 4x25mg
30% received either 3x25mg or 5x25mg
Then 100% of the subjects could be evaluated.
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
149 visitors (0 registered, 149 guests [including 17 identified bots]).
Forum time: 23:06 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5